Trading Update

MicroSalt PLC

12 January 2026

 

12 January 2026

MicroSalt Plc

("MicroSalt" or the "Company")

Trading Update

MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, is pleased to provide the following trading update and continuing advancement of its B2B bulk business for the financial year ended 31 December 2025 ("FY25").

The Group is delighted to announce that unaudited sales for FY25 exceeded the Board's original revenue expectations of $2.0 million, increasing by 287% year-on-year to $2.14 million (2024: $745k).

The Company continues to project 2026 sales to total $7.0 million based on in-hand volume estimations and its current customer base, rising to more than $15.0 million in 2027.

As outlined in the Company's Trading Update on 14 November 2025, MicroSalt has witnessed increased North America volume projections throughout 2025 from Customer 3, one of the world's largest food, soft drink and snack manufacturers. The increased volume projections included a new product that is due to commence in Q2 2026. The Company's first bulk order for this product has been delivered for a specific end retailer of Customer 3; in addition, further similar orders have been received on a broadly monthly basis since, in line with management expectations.

Rick Guiney, CEO of MicroSalt, commented:

"We are immensely proud to have exceeded Board expectations in 2025, delivering revenue growth of 287% compared to 2024. This performance is a clear testament to the strength of our offering, the versatility of MicroSalt's applications, and the successful execution of our strategy to build a sustainable and profitable organisation. Importantly, it reinforces our commitment to delivering healthier food alternatives globally while driving revenue growth and long-term value for our shareholders. Our final 2025 healthy servings totalled 830,735,462, providing clear evidence that MicroSalt is successfully delivering on its mission of enabling healthier foods by helping to reduce excess sodium consumption.

"We look forward to continuing our close collaboration with existing partners as we deepen relationships and expand our global reach. At the same time, we remain focused on establishing new partnerships that will support our next phase of growth. As we look ahead, we are confident in our ability to build on this momentum and continue strengthening the business for the benefit of both our customers and shareholders."

Enquiries:

MicroSalt plc	[e-mail]
Rick Guiney (CEO)
Zeus (Nominated Adviser and Broker)	[phone]
David Foreman / James Edis (Investment Banking)
Gracechurch Group (Financial PR)	[phone]
Heather Armstrong, Alexis Gore, Rebecca Scott

About MicroSalt

MicroSalt is disrupting the global salt market with its patented, full-flavour, low-sodium salt designed for both food manufacturers and consumers. Using proprietary micron-sized particles, MicroSalt delivers the same salty taste as traditional salt with approximately 50% less sodium, offering a scalable solution to one of the world's most pressing health challenges. Year to date through 2025, MicroSalt has contributed to more than 634M servings made healthier.

Excess sodium consumption is a leading contributor to cardiovascular disease, the world's number one cause of death. The World Health Organisation has targeted a 30% reduction in global sodium intake by 2025, a shift projected to save seven million lives by 2030. The economic case is equally compelling: in the UK alone, cardiovascular disease costs £19 billion annually, and reducing average daily salt intake by just one gram could save over 4,000 lives and £288 million each year. 

Operational since 2018, MicroSalt has established a defensible IP portfolio, holding a granted US patent and 14 pending applications worldwide. These protections create significant barriers to entry in a market expected to grow exponentially as regulation and consumer demand accelerate.

MicroSalt is ideally positioned for scale and market leadership, with clear pathways into food manufacturing, consumer channels, and ultimately the broader £10+ billion global salt market. MicroSalt is more than a healthier alternative-it is a disruptive, category-defining solution poised to deliver significant commercial and societal impact.

For more information, please visit www.microsaltinc.co or follow on X @microSaltPLC.

 

END